Variant report
Variant | nsv521981 |
---|---|
Chromosome Location | chr8:19626120-19632090 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:19626579..19627442-chr8:19636746..19637741,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7837390 | chr8:19626120-19626121 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs191748603 | chr8:19626223-19626224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184924732 | chr8:19626263-19626264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564812780 | chr8:19626280-19626281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527500633 | chr8:19626342-19626343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547151225 | chr8:19626350-19626351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs13254708 | chr8:19626356-19626357 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs529751063 | chr8:19626390-19626391 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188191592 | chr8:19626425-19626426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1994786 | chr8:19626439-19626440 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149165120 | chr8:19626441-19626442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558502411 | chr8:19626494-19626495 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1994787 | chr8:19626535-19626536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534394626 | chr8:19626539-19626540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12676952 | chr8:19626594-19626595 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs574116903 | chr8:19626646-19626647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs80274215 | chr8:19626654-19626655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556546138 | chr8:19626717-19626718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576382481 | chr8:19626721-19626722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544969619 | chr8:19626724-19626725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75680133 | chr8:19626726-19626727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113451974 | chr8:19626729-19626730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113158847 | chr8:19626750-19626751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs112882827 | chr8:19626760-19626761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529833128 | chr8:19626789-19626790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374264209 | chr8:19626805-19626806 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549631240 | chr8:19626806-19626807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs117109432 | chr8:19626833-19626834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs193177708 | chr8:19626862-19626863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558694530 | chr8:19626884-19626885 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572014557 | chr8:19626885-19626886 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534484367 | chr8:19626894-19626895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143267350 | chr8:19626901-19626902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35327513 | chr8:19626935-19626936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200790113 | chr8:19626936-19626937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74425877 | chr8:19626954-19626955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567734773 | chr8:19626986-19626987 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536829516 | chr8:19626994-19626995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556399392 | chr8:19627022-19627023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200984799 | chr8:19627101-19627102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574041718 | chr8:19627125-19627126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576444339 | chr8:19627130-19627131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535172852 | chr8:19627140-19627141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538654062 | chr8:19627249-19627250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558525580 | chr8:19627290-19627291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185425899 | chr8:19627337-19627338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs369997882 | chr8:19627345-19627346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs55684005 | chr8:19627356-19627357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561166228 | chr8:19627357-19627358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112424130 | chr8:19627360-19627361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 22083797 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 18840272 | CNVD |
Breast cancer | 19602461 | CNVD |
Osteosarcoma | 19286668 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 19258508 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:19624400-19626200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
2 | chr8:19625000-19626200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr8:19625200-19627600 | Enhancers | Placenta Amnion | Placenta Amnion |
4 | chr8:19625400-19626200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr8:19625400-19626200 | Enhancers | Pancreas | Pancrea |
6 | chr8:19625600-19626200 | Enhancers | Brain Hippocampus Middle | brain |
7 | chr8:19625600-19627600 | Enhancers | K562 | blood |
8 | chr8:19625800-19627000 | Weak transcription | Brain Anterior Caudate | brain |
9 | chr8:19626000-19627000 | Weak transcription | Brain Substantia Nigra | brain |
10 | chr8:19626200-19627000 | Weak transcription | Pancreas | Pancrea |
11 | chr8:19626200-19627200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr8:19626600-19627400 | Enhancers | Stomach Mucosa | stomach |
13 | chr8:19627000-19627600 | Enhancers | Brain Anterior Caudate | brain |
14 | chr8:19627000-19627600 | Enhancers | Brain Substantia Nigra | brain |
15 | chr8:19627000-19627600 | Enhancers | Pancreas | Pancrea |
16 | chr8:19627000-19627800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr8:19627400-19627600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr8:19627600-19628800 | Weak transcription | K562 | blood |
19 | chr8:19627800-19628200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr8:19628200-19628600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr8:19628800-19629600 | Enhancers | K562 | blood |